ABVX
Price
$92.73
Change
-$0.18 (-0.19%)
Updated
Oct 17 closing price
Capitalization
7.35B
57 days until earnings call
ANEB
Price
$2.66
Change
+$0.14 (+5.56%)
Updated
Oct 17 closing price
Capitalization
109.29M
19 days until earnings call
Interact to see
Advertisement

ABVX vs ANEB

Header iconABVX vs ANEB Comparison
Open Charts ABVX vs ANEBBanner chart's image
Abivax SA
Price$92.73
Change-$0.18 (-0.19%)
Volume$598.05K
Capitalization7.35B
Anebulo Pharmaceuticals
Price$2.66
Change+$0.14 (+5.56%)
Volume$17.78K
Capitalization109.29M
ABVX vs ANEB Comparison Chart in %
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANEB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABVX vs. ANEB commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVX is a Hold and ANEB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (ABVX: $92.73 vs. ANEB: $2.66)
Brand notoriety: ABVX and ANEB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVX: 54% vs. ANEB: 22%
Market capitalization -- ABVX: $7.35B vs. ANEB: $109.29M
ABVX [@Biotechnology] is valued at $7.35B. ANEB’s [@Biotechnology] market capitalization is $109.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVX’s FA Score shows that 0 FA rating(s) are green whileANEB’s FA Score has 0 green FA rating(s).

  • ABVX’s FA Score: 0 green, 5 red.
  • ANEB’s FA Score: 0 green, 5 red.
According to our system of comparison, ANEB is a better buy in the long-term than ABVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVX’s TA Score shows that 4 TA indicator(s) are bullish while ANEB’s TA Score has 4 bullish TA indicator(s).

  • ABVX’s TA Score: 4 bullish, 4 bearish.
  • ANEB’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ABVX is a better buy in the short-term than ANEB.

Price Growth

ABVX (@Biotechnology) experienced а -1.11% price change this week, while ANEB (@Biotechnology) price change was +14.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

ABVX is expected to report earnings on Dec 15, 2025.

ANEB is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABVX($7.35B) has a higher market cap than ANEB($109M). ABVX YTD gains are higher at: 1166.803 vs. ANEB (58.333). ANEB has higher annual earnings (EBITDA): -7.27M vs. ABVX (-170.04M). ABVX has more cash in the bank: 104M vs. ANEB (13.3M). ABVX (0) and ANEB (0) have equivalent revenues.
ABVXANEBABVX / ANEB
Capitalization7.35B109M6,744%
EBITDA-170.04M-7.27M2,340%
Gain YTD1166.80358.3332,000%
P/E RatioN/AN/A-
Revenue00-
Total Cash104M13.3M782%
Total Debt92.6MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ABVXANEB
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 6 days ago
87%
Bullish Trend 5 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 12 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANEB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HUGPF47.37N/A
N/A
Hugo Boss AG
IFLXF0.77N/A
N/A
Imaflex Inc
NVRVF0.05N/A
N/A
Novra Technologies Inc
HEXEY15.24N/A
N/A
Hellenic Exchanges SA
NEXOY20.42-0.28
-1.36%
Nexon Co Ltd.

ABVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVX has been loosely correlated with NEVPF. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVX jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVX
1D Price
Change %
ABVX100%
-0.19%
NEVPF - ABVX
65%
Loosely correlated
N/A
IMNN - ABVX
58%
Loosely correlated
+0.59%
ANEB - ABVX
52%
Loosely correlated
+5.56%
CLSD - ABVX
51%
Loosely correlated
+2.29%
CGON - ABVX
38%
Loosely correlated
-0.93%
More

ANEB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANEB has been loosely correlated with ABVX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ANEB jumps, then ABVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANEB
1D Price
Change %
ANEB100%
+5.56%
ABVX - ANEB
52%
Loosely correlated
-0.19%
AVXL - ANEB
31%
Poorly correlated
-0.33%
CLSD - ANEB
29%
Poorly correlated
+2.29%
TECX - ANEB
28%
Poorly correlated
-2.21%
ALDX - ANEB
28%
Poorly correlated
-2.41%
More